It's getting much harder to support $AAOI when they keep dropping $500m or $600M ATMs left and right.
At a certain point, the operating outlook could be positive.
But the share structure/financing becomes increasingly shareholder unfriendly.
Really, really, dislike ATMs and incessant capital raises, even if they're building up capacity.
The Moderna cancer vaccine is the first domino to fall.
There’s much more to come as AI accelerates the development of treatments and cures for major diseases.
AI in healthcare will be one of the defining themes and most consequential breakthroughs of this era.
中国科技行业下一轮最大的泡沫破裂,应该就是具身智能+VLA+世界模型,会有几个公司上市后股价跌到零,剩下一批公司应该跟AI四小龙时代的一批调参大师一样突然关停或者暴雷。
虽然具身智能+VLA+世界模型的泡沫破裂,远远比不上2000年的美国dot com bubble互联网泡沫危机,但肯定比AI四小龙要猛烈得多。
方式也跟AI四小龙时代一样,一批大厂senior level到VP分别下场做demo,手搓个垃圾pick and place跑不通的灵巧手,或者全员跳舞,或者弄一堆metaverse元宇宙级别的物理世界仿真4399小游戏,烧完就关门。
这一轮会比以前任何一轮都要惨烈,核心原因就是宇树科技IPO全面开绿灯,马上要冲击上市,这一两年国内PEVC投资人已经全部杀红了眼,随便一个垃圾phd、垃圾教授、垃圾demo都能投进去几个亿,等着一个个也IPO开绿灯,让A股股民接盘。
表面上是科技大泡沫、技术大骗局,实际上本质还是金融监管的巨大漏洞,让宇树科技抢跑上市,导致后患无穷。
Just putting it out there for people that think AAOI is a one year cycle...
$AAOI projects their ELSFP capacity for CPO to be 400K/units a month in 2028.
400k * ~$400 ELS ASP (GS assumptions) = + another ~$1.92B 2028 annualized revenue capacity added as a new distinct (>50% gross margin) product line.
On top of their existing 2027 projections (eg. ~$5.6B annualized transceiver revenue off $471m/month entering H2).
TAM for 1.6T also goes brrr so I'd expect their end of H2 2027 projections to go up as more capacity comes online...
For certain optical names, it's one cycle (eg. 1.6T, CPO scale out/up, NPO etc. ), stacked on top of one another... stacked on top of another... with TAM + margins stacking like minions after Anivia uses W in line.
Rather than one-and-done off of one year.
This is a stark contrast to some other sectors where growth is likely to decelerate after maybe 1 year of triple digit Y/Y revenue growth.